Symbiosis Capital Partners, Llc Portfolio Stock Holdings

According to the SEC 13F filed on May 12, 2026, Symbiosis Capital Partners, Llc disclosed 3 stock positions valued at approximately $52.77M as of quarter-end March 31, 2026. The largest holdings include Evommune, Inc., Rani Therapeutics Holdings, Inc., and Surrozen, Inc..

Report Period: March 31, 2026
No. of Stocks: 3
Portfolio Value: $52.77M

Holdings by Sector

Symbiosis Capital Partners, Llc Portfolio Holdings in Q1 2026

Company	Symbol	Sector	Portfolio %	Shares	Change (Shares)	Change %	Value
Evommune, Inc.	EVMN	Other	55.80%	1,280,778	-	-	$29,445,086
Rani Therapeutics Holdings, Inc.	RANI	Healthcare	5.11%	3,667,585	-2,632,415	-41.78%	$2,694,941
Surrozen, Inc.	SRZNW	Healthcare	0.00%	150,000	-	-	$2,400

Showing 3 of 3 holdings in the latest reporting period.